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Purpose: Hypoxia can impair the therapeutic efficacy of radiotherapy (RT). Therefore, a new strategy is necessary for enhancing 
the response to RT. In this study, we investigated whether the combination of nanoparticles and RT is effective in eliminating the 
radioresistance of hypoxic tumors.  
Materials and Methods: Gold nanoparticles (GNPs) consisting of a silica core with a gold shell were used. CT26 colon cancer 
mouse model was developed to study whether the combination of RT and GNPs reduced hypoxia-induced radioresistance. Hypoxia 
inducible factor-1α (HIF-1α) was used as a hypoxia marker. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were conducted to evaluate cell death. 
Results: Hypoxic tumor cells had an impaired response to RT. GNPs combined with RT enhanced anti-tumor effect in hypoxic 
tumor compared with RT alone. The combination of GNPs and RT decreased tumor cell viability compare to RT alone in vitro. Under 
hypoxia, tumors treated with GNPs + RT showed a higher response than that shown by tumors treated with RT alone. When a 
reactive oxygen species (ROS) scavenger was added, the enhanced antitumor effect of GNPs + RT was diminished. 
Conclusion: In the present study, hypoxic tumors treated with GNPs + RT showed favorable responses, which might be 
attributable to the ROS production induced by GNPs + RT. Taken together, GNPs combined with RT seems to be potential modality 
for enhancing the response to RT in hypoxic tumors. 
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Introduction
New technologies in radiotherapy (RT) have been developed 
to overcome the low tolerance of normal tissue and achieve a 
high therapeutic ratio. For example, image-guided RT has been 
used to identify the exact tumor location and the relationship 
between the tumor and normal organs. Intensity-modulated 
RT was developed to deliver high doses of radiation precisely 
to the tumor location by using a stiff dose gradient. Despite 
the use of these technologically advanced methods, tumor 
responses are limited in cases of hypoxic tumors. Hypoxia is a 
key regulatory factor in tumor growth [1] and plays a crucial 
role in RT resistance [2]. Furthermore, RT can result in cycling 
of hypoxia in tumor regions [3]. After RT, the lack of oxygen 
reduces the production of reactive oxygen species (ROS), and 
ultimately prevents irreparable DNA damage from occurring in 
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tumor cells, thereby preventing tumor cell death [4]. Hypoxia 
also leads to the up-regulation of hypoxia-inducible factor 1α 
(HIF-1α), which independently promotes radioresistance [5]. 
One of measures to overcome the limitations of RT is 
the use of nanoparticles in RT. Nanoparticles are utilized 
for various purposes in antitumor treatments, such as drug 
delivery [6,7], diagnosis [8,9], gene therapy [10], and RT [11]. 
When nanoparticles are combined with RT, absorbed radiation 
dose increases. In particular, the use of gold nanoparticle 
(GNPs) to enhance RT efficacy is well established [12,13]. 
GNPs can enhance RT efficacy owing to their high K-edge 
[14]. Studies have explained the enhancement of RT using 
GNPs in medical physics [15,16]. One of the reasons for the 
enhancement of RT efficacy when used in combination with 
GNPs is ROS production when GNPs are subjected to X-ray 
irradiation. This ROS generation differs depending on the 
composition, size, and potential of GNPs [17]. 
We hypothesized that increased ROS production due 
to GNPs combined with RT overcomes the limited effect 
of RT under hypoxic conditions. This study was aimed at 
investigating the enhancement of RT efficacy using GNPs 
and evaluating the potential for increasing RT efficacy under 
hypoxic conditions. 
Materials and Methods
1. Reagents
HIF-1α antibody was purchased from Abcam (Cambridge, UK), 
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was obtained from Sigma (St. Louis, MO, USA). 
2. GNP synthesis
The GNPs used in this study consisted of a silica core with a 
gold shell. Silica nanoparticles (SNPs) were functionalized with 
3-aminopropyl triethoxysilane to help attachment of gold 
seeds (1–2 nm). Gold seeds were deposited onto the SNPs. 
Further gold coverage of the SNPs was accomplished by the 
reduction of gold hydroxide by hydroxylamine hydrochloride 
on the SNP surface (Fig. 1A) [18].
 
3. Cell culture
Mouse CT26 colon cancer cells were used for all experiments. 
The cells were cultured in RPMI 1640 (Gibco, Carlsbad, CA, 
USA) supplemented with 10% fetal bovine serum  (FBS) and 
1% antibiotics and maintained at 37°C in a 5% CO2 incubator. 
They were subcultured every 3–4 days to maintain exponential 
growth. 
4. MTT assay
Mouse CT26 colon cancer cells (4 × 103 cells/well) were plated 
onto 96-well plates. After 24 hours, the cells were incubated 
with 2 μg/mL GNP for 24 hours at 37°C in a 5% CO2 incubator. 
After incubation, the cells were washed with phosphate 
buffered saline  (PBS) to remove excess GNPs. The effect of 
GNPs on cell viability was evaluated using the MTT assay at 24 
hours after GNP exposure. 
5. Apoptosis assay
For in vitro apoptosis assay, cells were treated GNP with 2 μg/
mL for 24 hours, which was washed with new media followed 
by irradiation with 8 Gy. After incubation for 48 hours, cells 
were stained with FITC-annexin V (BD Biosciences, San Jose, 
CA, USA) and propidium iodide (PI; BD Biosciences) for 15 
minutes. Apoptotic cells were evaluated by flow cytometry 
analyses using FACSVerse flow cytometer (BD Biosciences).
6.  Effect of the combination of GNPs and RT on cell growth 
under hypoxic conditions
To investigate the synergistic effect of GNPs and RT on cell 
growth inhibition under hypoxic conditions in comparison 
with that of RT alone, 4 × 103 cells/well were incubated with 
2 μg/mL GNP for 24 hours at 37°C in a 0.1% O2, 5% CO2, and 
balanced N2, respectively. After incubation, the cells were 
washed with PBS to remove excess GNPs followed by 8 Gy 
irradiation. A single fraction of 8 Gy was delivered to the 
tumor cells by using a X-RAD 320 irradiator (Precision X-Ray, 
North Branford, CT, USA) and cell viability was evaluated using 
the MTT assay.
7.  Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) staining
The  TUNEL  assay  was  per formed accord ing  to  the 
manufacturer’s instructions (Promega Co., Madison, WI, USA). 
Briefly, after deparaffinization and rehydration, tissue sections 
were incubated with proteinase K (20 μg/mL) for 15 minutes 
at 24°C and washed in PBS. The slides were incubated with 
a mixture of TdT enzyme and biotinylated nucleotide for 
60 minutes at 37°C. After being washed in PBS, the slides 
were incubated with streptavidin-horseradish peroxidase 
(HRP) solution for 30 minutes at 24°C. To detect TUNEL-
positive signals, the slides were incubated with a mixture 
of 3,3’-diaminobenzidine (DAB) substrate, chromogen, and 
hydrogen peroxide. The slides were then examined and the 
images were recorded using a microscope (Olympus BX53F; 
Olympus, Tokyo, Japan). Dark brown staining represented 
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Fig. 1. Gold nanoparticle (GNP) characterization. (A) Schematic illustration of the synthesis of GNPs. (B) Transmission electron 
micrograph of gold shell formation in SNP-GNPs (SNP-GNS) with different amounts of gold hydroxide solution: (a) 5 mL, (b) 10 mL, and (c) 
20 mL. (C) Color changes from SNP-GNP to SNP-GNS. (D) Absorption spectra of SNP-GNPs and SNP-GNS. (E) MTT viability assay of CT26 
cells treated with increasing concentrations of GNPs for 24 hours. Cells were incubated with 2 μg/mL GNP for 24 hours and washed 
with new media to remove excess GNPs. Cell viability was evaluated using the MTT assay at 24 hours after GNP exposure. Error bars, 
viability (mean ± standard deviation of three replicates). All experiments were performed in triplicate. MTT, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide; APTES, 3-aminopropyltriethoxysilane; THPC, tetrakis (hydroxymethyl) phosphonium chloride.  
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a positive reaction. Positive reactions showed under the 
microscope, and stained cells were quantified by stereological 
analysis using Image-J software (https://imagej.nih.gov/ij/).
8. ROS evaluation
CT26 cells were cultured in a 6-well plate for 24 hours 
followed by 6 Gy irradiation. After incubation for 2 hours, the 
cells were treated with a fluorogenic probe, as an indicator, 
for ROS detection and measurements were performed 
using a fluorescence microscope (Zeiss, Jena, Germany). 
Dichlorodihydrofluorescein, supplied as a diacetate ester 
(DCFH DA), is readily oxidized to the highly fluorescent 
dichlorofluorescein (DCF) after enzymatic or base-catalyzed 
cleavage of the diacetate groups; 10 mM N-acetyl-L-cysteine 
(NAC) was used as a ROS scavenger.
9. Tumor growth inhibition (TGI)
The CT26 mouse colon cancer model was developed to 
investigate the synergistic effect of GNP in combination 
with RT on tumor growth. We injected 106 CT26 mouse colon 
cancer cells into the thigh of BALB/c mice subcutaneously. 
When tumor diameter reached 6 mm or 12 mm, GNPs (100 
μg Au) were injected into tumors; thereafter, the tumors were 
irradiated with 10 Gy in a single fraction by using X-RAD 320 
irradiator (Precision X-Ray). The mice were placed at a distance 
of 69 cm from the radiation source and treated at a dose rate 
of 150 cGy/min with 300 kVp X-rays, using 12.5 mA and a 
X-ray beam filter consisting of 2.0 mm Al. Tumor volume was 
calculated using the formula 0.5 × ab2, where a is the long axis 
and b is the short axis of two orthogonal diameters. The mice 
were divided into the following 4 groups (A, control; B, GNPs; 
C, RT; D, GNPs + RT). Tumor growth delay was observed for 18 
days.
10. Immunofluorescence staining for HIF-1α detection
Twenty four hours after irradiation, mice were sacrificed. 
Tumors were fixed in 4% paraformaldehyde and embedded in 
paraffin. The blocks were cut into 5-μm-thick sections. Antigen 
retrieval was accomplished at 37°C with protease K solution. 
For immunofluorescence staining, deparaffinized sections 
were blocked with 10% normal horse serum for 1 hour and 
then incubated with primary antibodies against HIF-1α for 
overnight at 4°C (Abcam). After washing with PBS, the samples 
were incubated for 1 hour with a PE conjugated secondary 
antibody (Thermo Fisher Scientific, Waltham, MA, USA). 
Reactions showed under the fluorescence microscope, and 
HIF-1α stained cells were quantified using Image-J software. 
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Fig. 2. Enhancement of radiosensitivity using gold nanoparticles. (A) MTT viability assay of CT26 cells after 2, 8 Gy irradiation at various 
concentration of gold nanoparticles (GNPs). CT26 cells were pre-treated with GNPs at various concentrations for 24 hours and irradiated 
after washing with new media. After 48 hours, cell viability was evaluated by MTT assay. (B) Apoptosis assay in CT26 cells treated 
with radiotherapy (RT) and GNPs + RT. CT26 cells were treated GNP with 2 μg/mL for 24 hours, followed by irradiation with 8 Gy after 
washing. Cells were stained with FITC-annexin V and propidium iodide for detection of apoptotic cells at 48 hours after irradiation. All 
experiments were performed in triplicate. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. *p < 0.05.
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11. Statistical analysis
Tumor cell growth was compared using the Student t-test, 
and tumor growth was compared using repeated-measures 
ANOVA. A p-value less than 0.05 was considered statistically 
significant. All statistical analyses were performed using SPSS 
ver. 20.0 (IBM, Armonk, NY, USA).
Results
1. GNP characterization 
The GNPs were imaged using transmission electron microscopy 
(Fig. 1B). The formation of GNPs was first confirmed by the 
color of the nanoparticle-containing solution. As further 
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gold coverage was achieved, the color of the GNP-containing 
solution changed from brown to blue-green (Fig. 1C), and the 
absorbance peak of the solution widened and red-shifted (Fig. 
1D). After addition of 0.250 mM gold hydroxide, a fairly thick 
GNP was obtained. The mean diameter of the GNPs was 180 
nm. The resultant GNPs exhibited a small absorbance peak at 
540 nm [18]. The cytotoxicity of GNPs was evaluated using the 
MTT assay. GNPs did not affect cell viability until 100 μg/mL (Fig. 
1E). 
2. GNPs enhanced the radiosensitivity of tumor cells
To investigate synergistic effect of GNPs used in combination 
with RT on TGI, CT26 cells were treated with GNPs in the 
absence or presence of radiation. After administration of 
2, 8 Gy in a single fraction to CT26 tumor cells, a dose-
response relationship was observed at various concentrations 
of GNPs (Fig. 2A). Tumor cells treated with 8 Gy showed less 
survival than that shown by the cells treated with 2 Gy. As 
the concentration of the GNPs increased, cell viability slightly 
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evaluation. (A) MTT viability assays 
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normoxic and hypoxic conditions. 
Error bars, viability (mean ± standard 
deviation of six replicates). (B) Relative 
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decreased. 
GNPs combined with RT increased apoptosis significantly 
(Fig. 2B). In comparison with cells treated with RT alone, those 
treated with GNPs + RT showed significantly greater apoptosis.
3.  Synergistic effect of GNPs in combination with RT on TGI 
in hypoxia 
To evaluate the effect of hypoxia on TGI, tumors with different 
diameters after treatment with 10 Gy in a single fraction 
were compared (Fig. 3A). While the tumor with a diameter 
of 6 mm showed significant TGI after irradiation, the tumor 
with a diameter of 12 mm did not show significant TGI. 
Immunohistochemical staining for HIF-1α showed that tumor 
with the diameter of 12 mm had more hypoxic tumor cells (Fig. 
3B). 
To evaluate the synergistic effect of GNPs in combination 
with RT under hypoxic conditions, tumor volumes of the mice 
in the 4 groups (A, B, C, and D) were compared (Fig. 3C). Group 
D (GNPs + RT) showed better TGI than that shown by group 
C (RT). During the follow-up period, groups A-C showed no 
difference in tumor volume. Apoptosis after irradiation was 
investigated using TUNEL staining. The number of TUNEL-
positive cells increased in group D compared to those in 
groups A-C (Fig. 3D). 
4. GNP induced ROS-dependent apoptosis
To investigate the mechanism of the synergistic effect of GNPs 
combined with RT, cell viability was compared using the MTT 
assay (Fig. 4A). Under normoxic conditions, GNPs combined 
with RT showed an enhanced antitumor effect on tumor 
cells. Tumor cells treated with GNPs + RT had lower survival 
than those treated with RT alone. Meanwhile, the improved 
antitumor effect diminished when NAC added. Under hypoxic 
conditions, the enhancement of the effect of RT due to GNPs 
was more notable. The effect of RT on cell viability under 
hypoxic conditions was slight. GNPs combined with RT showed 
a synergistic effect and the survival of the cells treated with 
GNPs + RT was significantly lower than that of the cells 
treated with RT alone. 
ROS generation was observed using a fluorogenic probe 
(Fig. 4B). Under normoxic conditions, ROS generation was 
detected in cells treated with RT. The fluorescence intensity 
increased significantly in the cells treated with GNPs + RT. 
Fluorescence intensity decreased upon addition of NAC, and 
the same patterns were observed under hypoxic conditions. 
The antitumor effect of GNPs + RT was correlated with ROS 
generation. When ROS generation increased, the survival 
of cells decreased. When ROS was removed using NAC, the 
survival of cells recovered. 
Discussion and Conclusion
Oxygen is well-established radiosensitizer. Free radicals 
generated after irradiation break the DNA double strand and 
induce biological damage in tumors. Oxygen fixes DNA damage, 
resulting in enhancement of RT efficacy [19]. Therefore, the 
oxygen effect is limited under hypoxic conditions. 
Tumor cells often are under hypoxic conditions. In particular, 
in large tumors, some tumor cells are located far from blood 
vessels. Tumor blood vessels are immature, and therefore, 
temporary obstruction occurs often. Hypoxic conditions 
affects both the DNA damage repair pathway and cell survival 
signaling pathway [20]. HIF-1α becomes activated in hypoxic 
conditions, and results in increased expression of genes related 
to angiogenesis, invasion and metastasis of tumor cells [3].
We observed that hypoxic tumor cells had an impaired 
response to RT. GNPs combined with RT enhanced the 
antitumor effect in hypoxic tumor cells. After irradiation, 
the survival of hypoxic tumor cells was higher than that of 
normoxic tumor cells. Addition of GNPs decreased tumor 
cell viability significantly. The tumor growth was impaired in 
both small tumor and large tumors after administration of 
10 Gy in a single fraction. However, large tumors, which had 
more hypoxic tumor cells, showed a poor response. When we 
evaluated tumor growth after the administration of 10 Gy in a 
single fraction, the tumors treated with GNPs + RT showed a 
higher response than that shown by the tumors treated with 
RT alone. With regard to tumor cell death, the cells treated 
with GNPs + RT and NAC showed a higher survival rate than 
that shown by the cells that were not treated with NAC. 
Apoptosis due to ROS was one of the main mechanisms of cell 
death.  
In clinical practice, stereotactic body radiotherapy (SBRT) 
is used to overcome the radioresistance of hypoxic tumors 
[21]. SBRT delivers an ablative radiation dose to the tumor 
area in 1–5 fractions. However, stereotactic radiosurgery and 
SBRT with the current doses cannot directly kill all the hypoxic 
cells in the tumor. GNPs when combined with RT enhance RT 
efficacy. Gold has a high atomic number. It is advantageous to 
interact with KeV energy radiation (photoelectric effect). Due 
to the photoelectric effect, short-range photo-Auger electrons 
emitted from the GNPs boost the tumor area while sparing the 
adjacent normal tissue.
Some studies pointed out the discrepancy between 
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predicted dose enhancement via a photoelectric effect and the 
radiobiological response of GNPs combined with RT [22,23]. 
Butterworth and colleagues focused on ROS. GNPs combined 
with RT elicit tumor cell responses mediated through oxidative 
stress. They suggested that oxidative stress via ROS is one of 
the main mechanisms of tumor response. GNPs contribute 
to increased ROS production when a tumor is irradiated. 
Misawa and colleagues studied the factors that affected ROS 
generation in the presence of GNPs [24]. The Auger electron 
and fluorescent X-ray, which were the resultants of interaction 
of ionizing radiation with GNPs, cause secondary water 
radiolysis. In addition to primary water radiolysis, secondary 
water radiolysis can produce additional ROS. Our study also 
showed increased ROS generation upon using GNPs. We used 
a cell-permeable fluorogenic probe to detect the presence of 
ROS. Tumor cells treated with GNPs + RT showed increased 
ROS generation.  
GNPs in combination with RT induce decreased clonogenic 
cell survival, increased apoptosis, and DNA damage [23], which 
are related to oxidative stress. Therefore, GNPs combined with 
RT may synergistically cause radiochemical damage via ROS 
[24]. In the present study, tumor cells treated with GNPs + 
RT exhibited increased apoptosis. It was correlated with ROS 
generation. In hypoxic conditions, GNPs enhanced RT efficacy. 
The viability of tumor cells decreased significantly when 
treated with GNPs + RT. However, the effect was diminished 
when a ROS scavenger was added. 
GNPs combined with RT may have boost effect to tumor 
area. Berbeco et al. [16] reported a boosting dose for tumor 
endothelial cells using megavoltage X-rays. They showed local 
dose enhancement for the tumor microvasculature by using 
linear accelerator X-ray. They found that GNPs combined 
with external-beam RT could deliver a prescribed dose to 
tumor cells and boost dose to the tumor microvasculature 
concomitantly. Tumors with disrupted microvasculature are 
deficient in nutrients and oxygen, which leads to necrosis. 
Rapid intratumoral necrosis results in remnant viable tumor 
cells around the margin of the necrotic area. The remnant 
viable tumor cells are close to normal tissue vasculature, and 
could be re-oxygenated, making them good targets for RT [25]. 
In our study, tumors treated with GNPs + RT showed better 
responses than those treated with RT alone during the follow-
up period. After administration of a single fraction of radiation, 
remnant viable tumor cells close to the normal vasculature 
might be re-oxygenated, and the oxygen effect might induce 
increased tumor cell death.
This study was insufficient to gather robust evidence for 
the enhancement of RT efficacy by GNPs to overcome hypoxia. 
GNPs were administered by intratumoral injection, and we 
could not be sure that they were distributed evenly in the 
tumor. The absorbed dose was not measurable. It could be odd 
that tumors with 12 mm diameter were defined as hypoxic 
tumors based on HIF-1α immunohistochemistry staining. 
Tumors in different size may have different characteristics. 
Furthermore, hypoxia is not the only factor that can influence 
on radiation sensitivity. In future studies, we should follow 
a way to make hypoxic tumor with similar size as a previous 
work [26].
Finally, in this study, GNPs combined with RT exhibited a 
favorable response in hypoxic tumors, which were resistant 
to RT. RT administered with high-tech therapeutic machinery 
alone has not shown a favorable effect in hypoxic tumors 
and tolerability in normal tissues, simultaneously. However, 
GNPs combined with RT enhanced ROS generation in hypoxic 
tumors, leading to tumor cell apoptosis. Thus, GNPs combined 
with RT may have potential for enhance the efficacy of RT. 
We expect further studies on clinical application of GNPs 
combined with RT.
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